WSFS
GMAB icon

Wilmington Savings Fund Society’s Genmab GMAB Stock Holding History

Wilmington Savings Fund Society’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-240
Closed -$4.7K – 2084
2025
Q1 		$4.7K Sell
240
-167
-41% -$3.5K ﹤0.01% 1791
2024
Q4 		$8.49K Buy
407
+19
+5% +$417 ﹤0.01% 1689
2024
Q3 		$9.46K Buy
+388
New +$10.4K ﹤0.01% 1647

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Wilmington Savings Fund Society's GMAB Position: Q2 2025 in Review

Wilmington Savings Fund Society sold out of Genmab (GMAB) in Q2 2025, closing a stake of 240 shares — an estimated $4.7K sold.

Wilmington Savings Fund Society first reported a position in GMAB in Q3 2024 and held it in 3 quarters. The position peaked at $9.46K in Q3 2024. 218 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • Wilmington Savings Fund Society reported no remaining Genmab position as of Q2 2025 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 240 Genmab shares in Q2 2025, an estimated $4.7K.
  • Wilmington Savings Fund Society first reported a position in Genmab in Q3 2024 and held it in 3 quarters.
  • Wilmington Savings Fund Society's Genmab position peaked at $9.46K in Q3 2024.
  • 218 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2025, filed 28 Jul 2025.